Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Finding Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Conditions
Interventions
CX11
Placebo
Locations
46
United States
Central Research Associates - Flourish - PPDS
Birmingham, Alabama, United States
AES - DRS - Synexus Clinical Research US, Inc. - Birmingham
Birmingham, Alabama, United States
AES - DRS - Optimal Research Alabama - Huntsville
Huntsville, Alabama, United States
Ark Clinical Research - Long Beach
Long Beach, California, United States
Flourish Research - Walnut Creek - PPDS
Walnut Creek, California, United States
AES - DRS - Optimal Research Florida - Melbourne
Melbourne, Florida, United States
Start Date
February 6, 2026
Primary Completion Date
December 23, 2026
Completion Date
January 7, 2027
Last Updated
April 17, 2026
NCT07350694
NCT06561126
NCT07362953
NCT02710448
NCT05563090
NCT06652971
Lead Sponsor
Corxel Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions